Background Progress in characterising the humoral immune response to Severe Acute
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist. …

Background Understanding the T cell response to SARS-CoV-2 is critical to vaccine
development, epidemiological surveillance and disease control strategies. This systematic review …

Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …

Much of routine cancer care has been disrupted due to the perceived susceptibility to SARS-CoV-2
infection in cancer patients. Here, we systematically review the current evidence …

Background BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have
been rapidly rolled out in the UK from December, 2020. We aimed to determine the factors …

Vaccines based on the spike glycoprotein of SARS-CoV-2 are being rolled out globally to
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …

Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-…

Background There is an urgent need to better understand whether individuals who have
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …

Background Neoadjuvant chemotherapy (NAC) followed by surgery for resectable oesophageal
or gastric cancer improves outcome when compared with surgery alone. However NAC …

Background Long-term care facilities (LTCFs) have reported high SARS-CoV-2 infection
rates and related mortality, but the proportion of infected people among those who have …